Table 3.
Cigarettes |
Commercial |
iqmik |
||||
---|---|---|---|---|---|---|
n | ϱ | n | ϱ | n | ϱ | |
Cotinine (M) – Cotinine (N) | 35 | 0.83 *** | 8 | 0.9 * | 16 | 0.85 *** |
NNAL (M) – NNAL (N) | 35 | 0.76 *** | 9 | 0.92 *** | 16 | 0.80 *** |
NNAL (M) – Cotinine (M) | 35 | 0.78 *** | 9 | 0.75 * | 16 | 0.65 * |
NNAL (M) – Cotinine (N) | 34 | 0.71 *** | 8 | 0.83 * | 16 | 0.59 * |
NNAL (N) – Cotinine (N) | 35 | 0.74 *** | 8 | 0.64 | 16 | 0.39 |
NNAL (N) – Cotinine (M) | 36 | 0.73 *** | 9 | 0.6 | 16 | 0.36 |
Maternal and Neonatal Biomarker Correlations by Tobacco Product. M: Maternal, N: Neonatal, *: p < 0.05, ***: p < 0.001. Units – Maternal Cotinine: ng/mg creat, Neonatal Cotinine: ng/ml, Maternal NNAL: pg/mg creatinine, Neonatal NNAL: pg/ml